Error: Could not add to watchlist. X

CFS Managed Investment Fund - Global Health & Biotechnology

+ Watchlist
COLFHLB:AU
2.3799
AUD
0.0115
0.49%
As of 00:59:30 ET on 08/28/2015.
Fund Type
Unit Trust
52Wk Range
1.4649 - 2.4791
1 Yr Return
61.01%
YTD Return
28.44%
Previous Close
2.3684
52Wk Range
1.4649 - 2.4791
1 Yr Return
61.01%
YTD Return
28.44%
Fund Type
Unit Trust
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 08/28/2015)
2.3799
Total Assets (m AUD) (on 02/27/2015)
26.299
Inception Date
04/28/2000
Last Dividend (on 06/30/2015)
-
Dividend Indicated Gross Yield
-
Fund Managers
DAVID L LEARY
Front Load Fee
4.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
2.05%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Bristol-Myers Squibb Co 18.95 k 1.59 m 6.05
Medtronic PLC 15.77 k 1.56 m 5.95
Gilead Sciences Inc 9.34 k 1.36 m 5.19
Allergan plc 3.02 k 1.21 m 4.60
Regeneron Pharmaceuticals Inc 1.49 k 999.37 k 3.80
McKesson Corp 3.13 k 970.44 k 3.69
UnitedHealth Group Inc 5.88 k 920.47 k 3.50
Aetna Inc 5.54 k 852.09 k 3.24
HCA Holdings Inc 6.20 k 662.74 k 2.52
Alkermes PLC 7.48 k 596.99 k 2.27
Profile
CFS Managed Investment Fund - Global Health & Biotechnology is a unit trust incorporated in Australia. The objective of the Fund is to provide long-term capital growth by predominantly investing in companies around the world, whose primary business is in the fields of pharmaceuticals, biotechnology, medical devices, or medical services.
ADDRESS
Colonial First State Asset Mgt Ltd
11 Harbour Street
Sydney NSW 2000
Australia
PHONE
Tel: 61-2-9303-3000